• Home
  • CADD software
    • Back
    • Overview

    • desktop

      • Flare™ Agile ligand-based and structure-based drug design solution
      • Spark™ Scaffold hopping and R-group replacement to generate innovative ideas for your discovery projects

    • Server

      • Blaze™ Ligand-based virtual screening to dramatically increase your screening hit rate at a fraction of the cost
  • Torx DMTA
    • Back
    • Overview
    • Torx Design Enhance molecule design by accessing all key project information
    • Torx Make Track and manage compound synthesis across in-house and CRO projects
    • Torx Test Automate assay scheduling and monitor real-time progress
    • Torx Analyze Analyze design outcomes to drive inspiration and decision making
    • Torx case studies and application notes Real world stories from Torx customers
    • Why Torx? Torx for chemists, research managers and CROs
  • Discovery CRO
    • Back
    • Overview
    • Why Cresset Discovery? As your computational chemistry CRO, we bring a unique perspective to help you advance your discovery project performance
    • Discovery capabilities Examples of the consultancy provided to advance your project
      • Back
      • Overview
      • Bridge resource gaps
      • Broaden and protect your IP position
      • Find a chemical starting point
      • Reposition existing drugs
      • Manage your procurement process
      • Develop bespoke software
      • Innovative 3D clustering method created to deliver diverse fragment libraries
      • Define the bioactive conformation
      • Run virtual screens
      • Modeling structures of novel biological targets
      • Conduct ligand-protein docking
      • Deducing ligand-protein interactions
      • Identify new chemical series
      • Grow and link fragments
      • Analyze SAR and property data
      • Streamline optimization
      • Create and analyze 3D-QSAR
      • Novel patentable chemistry
      • Move from hit to lead
      • Reduce risk and increase value in your life science investments
      • Identify and avoid problematic active sites
      • Helping to understand protein conformations with molecular dynamics
      • Identifying allosteric pockets
      • The business case for specialist modelers running your FEP calculations
      • Protein preparation
      • Orotomides, a new class of DHODH targeting anti-fungal drugs
      • Novel seed treatment discovered and patented
      • Discovering a Novel Therapy for Urinary Tract Infections Through Outsourcing In-silico Drug Discovery
      • Identifying promising inhibitors against epilepsy using virtual screening
      • Grant applications
      • Free Energy calculations study for the identification of potential inhibitors of SARS-CoV-2 Mpro cystein protease
    • Our expertise We are the best at what we do
    • Cresset Discovery case studies Case studies we have permission to publish
    • Discovery webinar recordings Request webinars to watch
  • User
    • Back
    • Overview
    • Computational chemists Results you can rely on
    • Medicinal chemists Make better design decisions
    • Biologists We help you remove obstacles
    • Academics Solutions for teaching and research
    • CROs Connect chemists from all organizations in a secure workspace
    • Research Managers Capture project data in one place and allocate resources effectively
  • Science
    • Back
    • Overview
    • Science overview Robust science for results you can rely on
    • Citations See users' published work
    • Resources Case studies, presentations, posters, publications
    • Scientific Advisory Board The Scientific Advisory Board provides guidance to the Cresset science team in their research
  • Support
    • Back
    • Overview
    • Support resources Installation guides, product releases, tips and tricks
    • Product releases Release notes
    • Installation Installing desktop applications
    • Tips and tricks Videos and step-by-step instructions
    • Citing Cresset applications
    • CADD Software webinar recordings Request webinars to watch
  • About
    • Back
    • Overview
    • About Cresset Helping you win the race to scientific success
    • Testimonials See what our customers say about our software and services
    • News Computational chemistry news and blog, including newsletters and press releases
    • Board Board of Directors
    • Partners We partner with third parties to deliver fully integrated solutions
    • Events Meet us at upcoming events
    • Careers Transform your future with us
    • ESG Environmental, social and corporate governance
    • Distributors Global distribution network
    • Contact us Request a CADD Software evaluation, Torx DMTA demo or Discovery CRO discussion
    • Location Cresset locations
  • Home
  • CADD software
    • Back
    • CADD software

    • desktop

      • Flare™
      • Spark™

    • Server

      • Blaze™
  • Torx DMTA
    • Back
    • Torx DMTA
    • Torx Design
    • Torx Make
    • Torx Test
    • Torx Analyze
    • Torx case studies and application notes
    • Why Torx?
  • Discovery CRO
    • Back
    • Discovery CRO
    • Why Cresset Discovery?
    • Discovery capabilities
      • Back
      • Discovery capabilities
      • Bridge resource gaps
      • Broaden and protect your IP position
      • Find a chemical starting point
      • Reposition existing drugs
      • Manage your procurement process
      • Develop bespoke software
      • Innovative 3D clustering method created to deliver diverse fragment libraries
      • Define the bioactive conformation
      • Run virtual screens
      • Modeling structures of novel biological targets
      • Conduct ligand-protein docking
      • Deducing ligand-protein interactions
      • Identify new chemical series
      • Grow and link fragments
      • Analyze SAR and property data
      • Streamline optimization
      • Create and analyze 3D-QSAR
      • Novel patentable chemistry
      • Move from hit to lead
      • Reduce risk and increase value in your life science investments
      • Identify and avoid problematic active sites
      • Helping to understand protein conformations with molecular dynamics
      • Identifying allosteric pockets
      • The business case for specialist modelers running your FEP calculations
      • Protein preparation
      • Orotomides, a new class of DHODH targeting anti-fungal drugs
      • Novel seed treatment discovered and patented
      • Discovering a Novel Therapy for Urinary Tract Infections Through Outsourcing In-silico Drug Discovery
      • Identifying promising inhibitors against epilepsy using virtual screening
      • Grant applications
      • Free Energy calculations study for the identification of potential inhibitors of SARS-CoV-2 Mpro cystein protease
    • Our expertise
    • Cresset Discovery case studies
    • Discovery webinar recordings
  • User
    • Back
    • User
    • Computational chemists
    • Medicinal chemists
    • Biologists
    • Academics
    • CROs
    • Research Managers
  • Science
    • Back
    • Science
    • Science overview
    • Citations
    • Resources
    • Scientific Advisory Board
  • Support
    • Back
    • Support
    • Support resources
    • Product releases
    • Installation
    • Tips and tricks
    • Citing Cresset applications
    • CADD Software webinar recordings
  • About
    • Back
    • About
    • About Cresset
    • Testimonials
    • News
    • Board
    • Partners
    • Events
    • Careers
    • ESG
    • Distributors
    • Contact us
    • Location
Cresset
CADD software
Desktop

About Cresset

Computational, medicinal and synthetic chemists use our software to make better molecule design decisions. As your CRO our expert scientists bring a unique perspective to advance drug discovery projects.

Links

  • Flare™
  • Spark™
  • Blaze™
  • Torx®
  • Science
  • Discovery
  • Events
  • LinkedIn
  • Twitter

Subscribe for computational chemistry news

Receive our newsletter to be among the first to hear about product releases, case studies, opinion articles, events and more.

Subscribe here

Copyright © 2023 Cresset. All rights reserved | Privacy notice | Registered as a company in England and Wales: 04151475 | VAT: GB 780 3418 32